El-Shanawany T - Search Results

1

Development of a high-throughput SARS-CoV-2 antibody testing pathway using dried blood spot specimens.

Moat SJ, Zelek WM, Carne E, Ponsford MJ, Bramhall K, Jones S, El-Shanawany T, Wise MP, Thomas A, George C, Fegan C, Steven R, Webb R, Weeks I, Morgan BP, Jolles S. Moat SJ, et al. Among authors: el shanawany t. Ann Clin Biochem. 2021 Mar;58(2):123-131. doi: 10.1177/0004563220981106. Epub 2020 Dec 26. Ann Clin Biochem. 2021. PMID: 33269949 Free PMC article.

2

Survey of clinical allergy services provided by clinical immunologists in the UK.

El-Shanawany TM, Arnold H, Carne E, Misbah SA, Egner W, Wallington TB, Herriot R, Williams PE. El-Shanawany TM, et al. J Clin Pathol. 2005 Dec;58(12):1283-90. doi: 10.1136/jcp.2005.027623. J Clin Pathol. 2005. PMID: 16311348 Free PMC article.

3

Current clinical uses of intravenous immunoglobulin.

El-Shanawany T, Sewell WA, Misbah SA, Jolles S. El-Shanawany T, et al. Clin Med (Lond). 2006 Jul-Aug;6(4):356-9. doi: 10.7861/clinmedicine.6-4-356. Clin Med (Lond). 2006. PMID: 16956140 Free PMC article. Review. No abstract available.

4

Response of refractory immune thrombocytopenic purpura in a patient with common variable immunodeficiency to treatment with rituximab.

El-Shanawany TM, Williams PE, Jolles S. El-Shanawany TM, et al. J Clin Pathol. 2007 Jun;60(6):715-6. doi: 10.1136/jcp.2006.041426. Epub 2007 May 4. J Clin Pathol. 2007. PMID: 17483248 Free PMC article. No abstract available.

5

Intravenous immunoglobulin and autoimmune disease.

El-Shanawany T, Jolles S. El-Shanawany T, et al. Ann N Y Acad Sci. 2007 Sep;1110:507-15. doi: 10.1196/annals.1423.054. Ann N Y Acad Sci. 2007. PMID: 17911466

6

Clinical immunology review series: an approach to the patient with anaphylaxis.

El-Shanawany T, Williams PE, Jolles S. El-Shanawany T, et al. Clin Exp Immunol. 2008 Jul;153(1):1-9. doi: 10.1111/j.1365-2249.2008.03694.x. Clin Exp Immunol. 2008. PMID: 18577027 Free PMC article. Review.

7

Patients with anaphylaxis in accident and emergency are not referred to specialised allergy services.

El-Shanawany T, Seddon L, Jolles S, Carne E, Dowd H, Williams P. El-Shanawany T, et al. J Clin Pathol. 2010 Apr;63(4):375. doi: 10.1136/jcp.2009.068577. J Clin Pathol. 2010. PMID: 20354215 No abstract available.

8

Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin home therapy in a patient with primary immunodeficiency.

Knight E, Carne E, Novak B, El-Shanawany T, Williams P, Pickersgill T, Jolles S. Knight E, et al. J Clin Pathol. 2010 Sep;63(9):846-7. doi: 10.1136/jcp.2010.076828. Epub 2010 Jul 29. J Clin Pathol. 2010. PMID: 20671049 No abstract available.

9

Serum killing of Ureaplasma parvum shows serovar-determined susceptibility for normal individuals and common variable immuno-deficiency patients.

Beeton ML, Daha MR, El-Shanawany T, Jolles SR, Kotecha S, Spiller OB. Beeton ML, et al. Immunobiology. 2012 Feb;217(2):187-94. doi: 10.1016/j.imbio.2011.07.009. Epub 2011 Jul 12. Immunobiology. 2012. PMID: 21802767

10

Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosis.

Cossburn MD, Harding K, Ingram G, El-Shanawany T, Heaps A, Pickersgill TP, Jolles S, Robertson NP. Cossburn MD, et al. Neurology. 2013 Jan 1;80(1):55-61. doi: 10.1212/WNL.0b013e31827b5927. Epub 2012 Dec 12. Neurology. 2013. PMID: 23243077 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page